Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Core EBITDA Growth

    Back to All Ratios
LASA SUPERGENERICS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for LASA SUPERGENERICS
Please provide your vote to see the results

LASA SUPERGENERICS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 148.85-129.21-65.6056.89160.58

What is the latest Core EBITDA Growth ratio of LASA SUPERGENERICS ?

The latest Core EBITDA Growth ratio of LASA SUPERGENERICS is 148.85 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024148.85
Mar2023-129.21
Mar2022-65.60
Mar202156.89
Mar2020160.58

How is Core EBITDA Growth of LASA SUPERGENERICS Trending?

Years Core EBITDA Growth % Change
Mar2024 148.85
Positive
Mar2023 -129.21
Negative
Mar2022 -65.6
Negative
Mar2021 56.89
-64.57
Mar2020 160.58 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Core EBITDA Growth ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹51.6 Cr -1.7% -16% -57.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,607.0 Cr -5.9% -2.8% -5.3% Stock Analytics
DIVIS LABORATORIES ₹170,148.0 Cr -3.7% -6.9% 30.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,471.0 Cr -3.8% 7.1% 12% Stock Analytics
CIPLA ₹121,103.0 Cr -3.9% -0.8% -0.9% Stock Analytics
DR REDDYS LABORATORIES ₹101,306.0 Cr -6% -7.3% -12% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

-1.7%

-16%

-57.4%

SENSEX

-0.8%

-3.3%

-1.4%


You may also like the below Video Courses